Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Social cognition, which refers to the ability to interpret social information and behave accordingly in a social environment, is crucial in everyday life. But this ability has been shown to be altered in patients with epilepsy, especially in medial temporal lobe epilepsy, which leads to a deterioration in the patient's quality of life. However, the mechanisms of those deficiencies remain largely unknown. The Team objective is to achieve a structural and functional cartography of the social cognition network in 20 healthy subjects and 20 patients with drug-resistant medial temporal lobe epilepsy (before and one year after resective surgery of the epileptogenic focus). Social cognition deficiencies will be assessed using a specifically dedicated neuropsychological assessment validated in French (Batteries de Cognition Sociale BCS). Brain structural analyses will be performed on a 3-Tesla MRI (3T MRI), including an anatomical T1 sequence, a High Angular Resolution Diffusion Imaging (HARDI) to assess the morphology and macrostructural characteristics of long and short white matter tracts involved in social cognition, and quantitative MRI and Hybrid Diffusion Imaging (HYDI) to assess their microstructure. Functional connectivity will be assessed using an ultra-high-field 7-Tesla MRI (7T MRI), with acquisition in resting state and during specific social cognition tasks. Joint analysis of structural and functional connectivity will enable the team to assess the alterations of social cognition networks in patients with epilepsy and their reorganisations after epilepsy surgery.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥ 18 years old - Good understanding of written and verbal French language - Written consent signed by the subject - Patients with focal temporal lobe epilepsy for at least one year, drug-resistant, due to a hippocampal sclerosis - Undergoing presurgical assessment - Affiliated to a social security system Who Should NOT Join This Trial: - Under juridical protection - With claustrophobia or any MRI contra-indication - Pregnancy or lactation - Participation in another research with an exclusion period - Refusal to be notified in the event of anomalies discovered during the performance of an MRI sequence Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion criteria: * Age ≥ 18 years old * Good understanding of written and verbal French language * Written consent signed by the subject * Patients with focal temporal lobe epilepsy for at least one year, drug-resistant, due to a hippocampal sclerosis * Undergoing presurgical assessment * Affiliated to a social security system Exclusion criteria: * Under juridical protection * With claustrophobia or any MRI contra-indication * Pregnancy or lactation * Participation in another research with an exclusion period * Refusal to be notified in the event of anomalies discovered during the performance of an MRI sequence

Treatments Being Tested

RADIATION

MRI 3T and MRI 7T

MRI 3T and MRI 7T before and post epilepsy surgery

Locations (2)

NeuroSpin - CEA
Gif-sur-Yvette, France
Unité d'épilepsie - GHU Pitié Salpêtrière
Paris, France